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A B S T R A C T 
The purpose of this research paper was to investigate the chlorophyllipt extract fungicidal action 
against Candida spp. fungi. 
We studied the reference strain C. albicans, clinical strains of C. albicans and C. glabrata, isolated 
from patients of surgical units. The sensitivity assessment  was performed on the derived strains 
for chlorophyllipt and ethanol using double serial dilutions according to the standard procedure. 
According to the results, the reference and clinical strains of Candida were sensitive to the action 
of the chlorophyllipt extract. The control strain of C. albicans was found to be the most sensitive at 
the time, as the antifungal effect of the extract studied against the clinical strains did not differ 
significantly from each other. In turn, it was found that ethanol had a weaker fungicidal action. 
The results of the study prove the antifungal effect of the chlorophyllipt extract against Candida 
spp. isolated from patients of surgical units. 
 
© EuroMediterranean Biomedical Journal  2018 
1. Introduction 
Postoperative infectious complications are one of the most preventive 
infections associated with a medical service and are a significant problem 
for healthcare systems around the world, from the position of incidence 
and morbidity [1, 2].  
The etiology of infectious complications in general surgery has not 
changed in the past 30 years. Gram-positive microorganisms such as 
coagulase-negative staphylococci, Enterococcus spp., along with gram-
negative pathogens of Escherichia, Enterobacter, Klebsiella, 
Pseudomonas genera are its basis. Previously, it was believed that yeast-
like fungi (Candida spp. mainly) cause approximately 3% of postoperative 
infectious complications [3, 4]. However, their role in developing diseases 
in severe surgical patients has grown substantially in recent years. Thus, 
representatives of the Candida genus are in sixth place among main 
hospital pathogens and fourth among nosocomial bacteremias. Until 
recently, in the majority of countries, the dominant species among them 
was C. albicans causing two-thirds of all cases of invasive candidiasis. 
Simultaneously, changes are occurring in an epidemiology of the 
candidiasis infection with a progressive shift towards non-albicans species  
such as C. glabrata, C. krusei [5 - 7]. 
 
This is associated with an increase of using azoles (fluconazole, 
itraconazole, clotrimazole, etc.), which are showing high fungistatic action 
against C. albicans in prevention and treatment of postoperative fungal 
complications. At the same time, non-albicans species C. glabrata and C. 
krusei are demonstrating considerable resistance to these drugs that 
promote their uncontrolled growth in surgical inpatients [6, 8]. 
In this regard, an increase of scientific interest related to the search for 
new alternative drugs that possess antifungal properties not only against 
C. albicans but other representatives of this species to an equal extent is 
natural.This will help to improve an efficiency of candidiasis prevention 
and treatment in severe surgical, burn, and intensive care inpatients [9]. 
Drugs based on plant extracts, with little to no side effects and show good 
antimicrobial activity, are considered as perspective [10 - 13]. 
The purpose of this study is to analyze an antifungal action of the 
chlorophyllipt extract on Candida spp. fungi.  
2.  Material and methods 
For the study, we used the standard strain of C. albicans (American Type 
Culture Collection (АТСС) 10231) received from the Public Institution 
“Institute of Epidemiology and Infectious Diseases L.V. Gromashevsky 
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National Academy of Medical Sciences of Ukraine” (Kyiv), 5 clinical 
strains of C. albicans and 5 clinical strains of C. glabrata, which were 
isolated from inpatients of thoracic and vascular surgery departments and 
were identified in the bacteriological laboratory of M.V. Sklifosovsky 
Poltava Regional Clinical Hospital. We tested an alcohol solution of 
chlorophyllipt, which contained a chlorophyllipt thick extract as the active 
substance and 96% ethanol (Halychpharm, JSC, Lviv, Ukraine, 
№ UA/4551/02/01 from 31.10.2016) as an excipient, for determination of 
the antifungal action. The sensitivity assessment of the derived strains to 
the chlorophyllipt extract was performed using double serial dilutions 
according to the standard procedure approved by the Order № 167 of the 
Ministry of Public Health of Ukraine on “On Approval of Training 
Guidance “Assessment of the sensitivity of microorganisms to antibiotics” 
[14]. 
The tests were conducted in a 0.5 cm3 volume of each dilution of the 
extract with a final concentration of the microbial culture 106 CFU/cm3. 
1.0 cm3 of the Sabouraud broth was transferred into each of the 10 vials 
considering “positive” and “negative” controls. A serial dilution series in 
the Sabouraud broth with 1.0ml of the alcohol solution of chlorophyllipt 
was prepared, which contained 10.0mg of a dry matter of the 
chlorophyllipt thick extract in recalculation on 100%. For inoculation we 
used a microbial suspension equivalent to 0.5 by McFarland Equivalence 
Standards diluted 1/100 in saline, and then the concentration of 
microorganisms in this suspension was 5x105 CFU/cm3. 0.5 cm3 of the 
suspension was added to each vial with the chlorophyllipt extract and into 
one vial with the Sabouraud broth without the testing drug as a negative 
control. The vials with dilutions were incubated in a normal atmosphere at 
the temperature 37 °C for 48 hours. Determination of the minimal 
inhibiting concentration of the testing solution was difficult because of the 
appearance of opacities. Therefore, we determined the minimum 
fungicidal concentrations (MFCs) of the extract by placing 
microorganisms from 10 vials on sectors of Petri dishes containing solid 
nutrient medium Sabouraud, and then incubated at 370С for an additional 
48 hours. The MFC was considered as the maximal dilution of the 
chlorophyllipt extract when growth of microorganisms was absent.  
An action of 96% ethanol (Private Enterprise "Kilaff", Sumy, Ukraine), 
which is a part of the test solution, against Candida spp. was estimated as 
a control. 
The statistical analysis of data was conducted with a standard package of 
programs Microsoft Excel 2013, Statistica 6.0., where arithmetical mean 
(M), standard error of the mean (m) were calculated. The Student t-test 
was used to evaluate the degree of reliability of differences between 
groups. The results were considered statistically significant at p <0.05. 
 
3. Results 
The standard strain of C. albicans was the most sensitive to the 
chlorophyllipt extract and the MFC against it was 0.688±0.25 mg/ml 
(Figure 1). However, there was no significant difference in the antifungal 
action of the test extract against clinical strains of C. albicans and C. 
glabrata. The MFCs of the chlorophyllipt extract against them were 
1.38±0.45 mg/ml, 1.25±0.5 mg/ml respectively.   
It was also established that 96% ethanol had a weaker fungicidal action 
against the examined strains of yeast-like fungi.  
Moreover, it should be noted that its MFC was within the same limits both 
against the standard and clinical strains of Candida spp. Thus, the MFC of 
96% ethanol against the standard strain of C. albicans was 2.75±0.9 
mg/ml, the clinical strains of C. albicans – 2.88±1.7 mg/ml, and the 
clinical isolates of C. glabrata – 2.5±1.0 mg/ml. The MFC of 96% ethanol 
was 4.0 times higher than this figure of the chlorophyllipt extract for the 
standard strain, and 2.0 times higher than of the clinical isolates. 
 
 
 
Figure 1 - Susceptibility of Candida spp. to the alcohol extract of 
chlorophyllipt and 96% ethanol, M+m (* - in recalculation on the 
active substance; ** - reliability of results differences of the MFC of 
the chlorophyllipt extract comparatively to the MFC of 96% ethanol, 
p<0.05). 
 
4. Discussion 
Elaboration and implementation of drugs based on plant extracts into 
medical practice obtain significant relevance in an environment of a rapid 
development of resistance to known antibiotics in microorganisms. An 
antibacterial action of the chlorophyllipt extract against resistant to 
antibiotics strains of Staphylococcus spp., Pseudomonas spp., Listeria spp. 
has been extensively researched. This explains its successful use in a 
treatment of infectious processes associated with these pathogens [15 -17]. 
At the same time, there isn’t much information about its antifungal 
activity. A number of authors point to an ability of the extract to oppress 
vital activity of Fusarium graminearum, Fusarium asiaticum, Fusarium 
redolens f.sp. dianthus, Fusarium verticillioides, Fusarium oxysporum 
f.sp. lentis, Sclerotinia sclerotiorum, Aspergillus flavus, Aspergillus 
tubingensis, Botrytis cinerea and Cladosporium cladosporioides. 
However, according to the literature, the antifungal spectrum of the 
chlorophyllipt extract is limited to hyphal fungi, while its influence on 
yeast forms is insufficiently described [18, 19]. 
The results of the research submitted in this article prove antifungal action 
of the chlorophyllipt extract against Candida spp. isolated from surgical 
inpatients. It is quite natural that clinical isolates of this species were less 
sensitive to have an impact on the tested extract in comparison to the 
standard strain. A reliable distinction of the MFCs between the 
chlorophyllipt extract and the 96% ethanol, which is the excipient of the 
extract, against fungi of the Candida genus indicates the direct fungicidal 
action of the active substance of the studied drug.  
* 
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5. Conclusions 
The alcohol extract of chlorophyllipt has the antifungal action against 
yeast-like Candida spp. fungi, reliably oppressing vital activity both of 
standard and clinical representatives of this species. Moreover, the testing 
extract demonstrates an equally high antifungal activity against C. 
albicans and C. glabrata that reduces a risk of postoperative candidiasis 
caused by non-albicans species and C. albicans. This allows us to look at 
the possibility of expanding the indications of the alcohol extract of 
chlorophyllipt usage in treatment and prevention of postoperative 
candidiasis in severe inpatients. 
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